{"id":983195,"date":"2026-07-21T09:23:26","date_gmt":"2026-07-21T13:23:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/"},"modified":"2026-07-21T09:23:26","modified_gmt":"2026-07-21T13:23:26","slug":"teleflex-awarded-national-central-venous-access-agreement-with-premier-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/","title":{"rendered":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc."},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.<\/b><\/p>\n<p>WAYNE, Pa.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nTeleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions.<\/p>\n<p>\n\u201cAs healthcare systems continue to focus on patient safety, standardization, and operational efficiency, we are proud to expand access to Teleflex\u2019s vascular access portfolio through this agreement with Premier,\u201d said Cris Gomide, Vice President and General Manager, Vascular &amp; Emergency Medicine. \u201cOur Arrow\u2122 Brand of vascular access solutions are designed to support clinicians across the continuum of care, while helping healthcare organizations advance evidence-based practices, support workflow efficiency, and address risks associated with vascular access complications.\u201d<\/p>\n<p>\nArrowg+ard Blue Plus\u2122 Catheters from Teleflex feature broad-spectrum antimicrobial protection designed to help reduce the risk of catheter-related bloodstream infections.<sup>1-4<\/sup> Through the agreement, Premier members will have access to a broad range of Teleflex products, including:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nArrowg+ard Blue Plus\u2122 Central Venous Catheters<\/p>\n<\/li>\n<li>\nArrow\u2122 ErgoPack\u2122 Complete Systems<\/p>\n<\/li>\n<li>\nArrow\u2122 Arterial Catheters and Catheterization Kits<\/p>\n<\/li>\n<li>\nArrow\u2122 EZ-IO\u2122 Intraosseous Vascular Access System<\/p>\n<\/li>\n<li>\nArrow\u2122 Multi-Lumen Access Catheters (MAC)<\/p>\n<\/li>\n<li>\nArrow\u2122 Percutaneous Sheath Introducers (PSI)<\/p>\n<\/li>\n<\/ul>\n<p>\nFor more than 40 years, Teleflex has advanced vascular access innovation through its Arrow\u2122 Portfolio. Through this agreement, Premier members will have access to solutions designed to help healthcare systems:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nSupport evidence-based vascular access practices and guidelines<sup>5-8<\/sup><\/li>\n<li>\nStandardize vascular access products across care settings<\/p>\n<\/li>\n<li>\nMaintain high standards of patient care<\/p>\n<\/li>\n<li>\nSupport workflow efficiency<\/p>\n<\/li>\n<li>\nAddress costs and risks associated with vascular access complications and infections<sup>2-4,9-10<\/sup><\/li>\n<\/ul>\n<p>\nPremier is a leading technology-driven healthcare improvement company. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, advisory services and other solutions in service of our mission to improve the health of communities.<\/p>\n<p><b>About Teleflex Incorporated<br \/>\n<br \/><\/b>As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people\u2019s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.<\/p>\n<p>\nTeleflex is the home of Arrow\u2122, Barrigel\u2122, Deknatel\u2122, QuikClot\u2122, LMA\u2122, Pilling\u2122, R\u00fcsch\u2122, UroLift\u2122 and Weck\u2122 \u2013 trusted brands united by a common sense of purpose.<\/p>\n<p>\nAt Teleflex, we are empowering the future of healthcare. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.teleflex.com%2Fusa%2Fen%2F&amp;esheet=54572353&amp;newsitemid=20260721873533&amp;lan=en-US&amp;anchor=teleflex.com&amp;index=1&amp;md5=7d00cc97a3f4d68adf7e47e5d7d16532\">teleflex.com<\/a>.<\/p>\n<p><b>Forward-Looking Statements<br \/>\n<br \/><\/b>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management&#8217;s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.<\/p>\n<p><b>References<\/b>:<\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nRosenthal VD, Yin R, Jin Z, et al. Multicenter, Multinational, Prospective Cohort Study of the Impact of Chlorhexidine Impregnated vs. Plain Central Lines on Central Line-associated Bloodstream Infections. <i>Am J Infect Control<\/i>. 2025;53(8):862-868. doi:<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1016%2Fj.ajic.2025.03.002&amp;esheet=54572353&amp;newsitemid=20260721873533&amp;lan=en-US&amp;anchor=https%3A%2F%2Fdoi.org%2F10.1016%2Fj.ajic.2025.03.002&amp;index=2&amp;md5=d789f736f39ca38a804eb2009144a31e\">https:\/\/doi.org\/10.1016\/j.ajic.2025.03.002<\/a>. The Rosenthal et al. study is referenced for only the pre-specified CVC subgroup analysis, which excludes PICCs.<\/p>\n<\/li>\n<li>\nLorente L, Lecuona M, Jim\u00e9nez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. <i>Am J Infect Control<\/i>. 2014;42(3):321-324. doi:10.1016\/j.ajic.2013.09.022<\/p>\n<\/li>\n<li>\nLorente L, Lecuona M, Jim\u00e9nez A, et al. Cost\/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. <i>Am J Infect Control<\/i>. 2014;42(10):1130-1132.doi:10.1016\/j.ajic.2014.06.027<\/p>\n<\/li>\n<li>\nLorente L, Lecuona M, Jim\u00e9nez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. <i>Am J Infect Control<\/i>. 2016;44(12):1526-1529. doi:10.1016\/j.ajic.2016.04.236<\/p>\n<\/li>\n<li>\nO\u2019Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). 2. Atlanta, GA: Centers for Disease Control and Prevention; 2017.<\/p>\n<\/li>\n<li>\nBuetti, N., Marschall, J., Drees, M, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. <i>Infect Control Hosp Epidemiol<\/i>. 2022:1-17. doi:10.1017\/ice.2022.87.<\/p>\n<\/li>\n<li>\nNickel B, Gorski LA, Kleidon TM, et al. Infusion therapy standards of practice. <i>J InfusNurs<\/i>. 2024;47(suppl1):S1-S285. doi:10.1097\/NAN.0000000000000532.<\/p>\n<\/li>\n<li>\nOccupational Safety &amp; Health Administration Regulations (Standards \u2013 29 CFR). Part 1910.1030: Bloodborne pathogens. Occupational Safety &amp; Health Administration Web site. Accessed on February 12, 2020. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.osha.gov%2Flaws-regs%2Fregulations%2Fstandardnumber%2F1910%2F1910.1030&amp;esheet=54572353&amp;newsitemid=20260721873533&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.osha.gov%2Flaws-regs%2Fregulations%2Fstandardnumber%2F1910%2F1910.1030&amp;index=3&amp;md5=9a6eb66f1ec21efc87b9826289b6d0d2\">https:\/\/www.osha.gov\/laws-regs\/regulations\/standardnumber\/1910\/1910.1030<\/a>.<\/p>\n<\/li>\n<li>\nRupp ME, Lisco SJ, Lipsett PA, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine of Central Catheter-Related Infections. <i>Ann Intern Medicine<\/i>. 2005;143(8):570-580. doi:10.7326\/0003-4819-143-8-200510180-00007. Sponsored by Arrow (Teleflex).<\/p>\n<\/li>\n<li>\nAbouleish, YZ, Oldfield EC, Marik PE. Comparison of central-line\u2013associated bloodstream infections between central venous catheters lined by combined chlorhexidine and silver sulfadiazine versus silver ionotrophes alone: A before\u2013after\u2013before retrospective study. <i>Infect Control Hosp Epidemiol<\/i>. 2021;42(2):225-227. doi:10.1017\/ice.2020.423<\/p>\n<\/li>\n<\/ol>\n<p><i>Rx Only. CAUTION: Federal (USA) law restricts these devices to sale or use by or on the order of a physician.<\/i><\/p>\n<p><i>Arrowg+ard Blue Plus\u2122 Catheters are contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and\/or sulfa drugs.<\/i><\/p>\n<p><i>The Arrow\u2122 EZ-IO\u2122 Needle Sets are single use only. Failure to comply with this warning may result in serious medical consequences (e.g., life-threatening infection) and reduced performance (e.g., blunted needles). The Arrow\u2122 EZ-IO\u2122 System is indicated for intraosseous access anytime in which vascular access is difficult to obtain in emergent, urgent or medically necessary cases for up to 24 hours. For patients \u2265 12 years old, the device may be extended for up to 48 hours when alternate intravenous access is not available or reliably established.<\/i><i>The Arrow\u2122 EZ-IO\u2122 Intraosseous Access Procedure Tray is indicated for intraosseous access anytime in which vascular access is difficult to obtain in emergent, urgent or medically necessary cases for up to 24 hours. For patients \u2265 12 years old, the device may be extended for up to 48 hours when alternate intravenous access is not available or reliably established.<\/i><i>The Arrow\u2122 EZ-IO\u2122 System is contraindicated for: fracture in target bone; previous, significant orthopedic procedure at the site, prosthetic limb or joint; IO access (or attempted IO access) in targeted bone within past 48 hours; infection at the area of insertion; excessive tissue (severe obesity) and\/or absence of adequate anatomical landmarks.<\/i><\/p>\n<p><i>Information in this material is not a substitute for the product Instructions for Use. Refer to the package insert provided with the product for complete warnings, indications, contraindications, precautions, potential complications, and instructions for use.<\/i><\/p>\n<p><i>Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, Barrigel, Deknatel, ErgoPack, EZ-IO, LMA, Pilling, QuikClot, R\u00fcsch, UroLift and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and\/or other countries.<\/i><\/p>\n<p><i>Not all products may be available in all countries. Please contact your local representative.<\/i><\/p>\n<p><i>\u00a9 2026 Teleflex Incorporated. All rights reserved. MC-012103<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260721873533\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260721873533\/en\/<\/a><\/span><\/p>\n<p>\nTeleflex<br \/>\n<br \/>Lawrence Keusch<br \/>\n<br \/>Vice President, Investor Relations and Strategy Development<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investor.relations@teleflex.com\">investor.relations@teleflex.com<br \/>\n<\/a><br \/>610-948-2836<\/p>\n<p><b>KEYWORDS:<\/b> Pennsylvania United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Cardiology Practice Management Data Analytics Health Medical Devices Hospitals Health Technology Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260721873533\/en\/2710168\/3\/Teleflex_Global_Corporate_Brand_Logo_CMYK_Navy-White_%28002%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. WAYNE, Pa.&#8211;(BUSINESS WIRE)&#8211; Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions. \u201cAs healthcare systems continue to focus on patient safety, standardization, and operational efficiency, we are proud to expand access to Teleflex\u2019s vascular access portfolio through this agreement with Premier,\u201d said Cris Gomide, Vice President and General Manager, Vascular &amp; Emergency Medicine. \u201cOur Arrow\u2122 Brand of vascular &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-983195","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. WAYNE, Pa.&#8211;(BUSINESS WIRE)&#8211; Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions. \u201cAs healthcare systems continue to focus on patient safety, standardization, and operational efficiency, we are proud to expand access to Teleflex\u2019s vascular access portfolio through this agreement with Premier,\u201d said Cris Gomide, Vice President and General Manager, Vascular &amp; Emergency Medicine. \u201cOur Arrow\u2122 Brand of vascular &hellip; Continue reading &quot;Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T13:23:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.\",\"datePublished\":\"2026-07-21T13:23:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/\"},\"wordCount\":1280,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/\",\"name\":\"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-07-21T13:23:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/","og_locale":"en_US","og_type":"article","og_title":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk","og_description":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. WAYNE, Pa.&#8211;(BUSINESS WIRE)&#8211; Teleflex Incorporated (NYSE: TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions. \u201cAs healthcare systems continue to focus on patient safety, standardization, and operational efficiency, we are proud to expand access to Teleflex\u2019s vascular access portfolio through this agreement with Premier,\u201d said Cris Gomide, Vice President and General Manager, Vascular &amp; Emergency Medicine. \u201cOur Arrow\u2122 Brand of vascular &hellip; Continue reading \"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-21T13:23:26+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.","datePublished":"2026-07-21T13:23:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/"},"wordCount":1280,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/","name":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-07-21T13:23:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260721873533r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-awarded-national-central-venous-access-agreement-with-premier-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Teleflex Awarded National Central Venous Access Agreement with Premier, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=983195"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983195\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=983195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=983195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=983195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}